99 related articles for article (PubMed ID: 25987650)
21. Wavelet-based clustering for mixed-effects functional models in high dimension.
Giacofci M; Lambert-Lacroix S; Marot G; Picard F
Biometrics; 2013 Mar; 69(1):31-40. PubMed ID: 23379722
[TBL] [Abstract][Full Text] [Related]
22. Model selection in multivariate semiparametric regression.
Li Z; Liu H; Tu W
Stat Methods Med Res; 2018 Oct; 27(10):3026-3038. PubMed ID: 28164740
[TBL] [Abstract][Full Text] [Related]
23. On tests of equivalence via non-unity relative risk for matched-pair design.
Tang NS; Tang ML; Chan IS
Stat Med; 2003 Apr; 22(8):1217-33. PubMed ID: 12687652
[TBL] [Abstract][Full Text] [Related]
24. Blinded assessment of treatment effects for survival endpoint in an ongoing trial.
Xie J; Quan H; Zhang J
Pharm Stat; 2012; 11(3):204-13. PubMed ID: 22337644
[TBL] [Abstract][Full Text] [Related]
25. Statistical inference on censored data for targeted clinical trials under enrichment design.
Chen CF; Lin JR; Liu JP
Pharm Stat; 2013; 12(3):165-73. PubMed ID: 23606647
[TBL] [Abstract][Full Text] [Related]
26. Classification of longitudinal profiles using semi-parametric nonlinear mixed models with P-Splines and the SAEM algorithm.
Márquez M; Meza C; Lee DJ; De la Cruz R
Stat Med; 2023 Nov; 42(27):4952-4971. PubMed ID: 37668286
[TBL] [Abstract][Full Text] [Related]
27. Population enrichment designs: case study of a large multinational trial.
Mehta CR; Gao P
J Biopharm Stat; 2011 Jul; 21(4):831-45. PubMed ID: 21516572
[TBL] [Abstract][Full Text] [Related]
28. Optimization of adaptive designs: efficiency evaluation.
Menon S; Chang M
J Biopharm Stat; 2012; 22(4):641-61. PubMed ID: 22651106
[TBL] [Abstract][Full Text] [Related]
29. Functional mixed effects models.
Guo W
Biometrics; 2002 Mar; 58(1):121-8. PubMed ID: 11890306
[TBL] [Abstract][Full Text] [Related]
30. Simple fitting of subject-specific curves for longitudinal data.
Durbán M; Harezlak J; Wand MP; Carroll RJ
Stat Med; 2005 Apr; 24(8):1153-67. PubMed ID: 15568201
[TBL] [Abstract][Full Text] [Related]
31. Negative randomized trials.
Lee JT
J Am Coll Surg; 2013 Jul; 217(1):171-2. PubMed ID: 23791291
[No Abstract] [Full Text] [Related]
32. Reply: To PMID 23177270.
Brody B; Wray N; Ashton C
J Am Coll Surg; 2013 Jul; 217(1):172. PubMed ID: 23791292
[No Abstract] [Full Text] [Related]
33. Generalized Linear Mixed Models with Gaussian Mixture Random Effects: Inference and Application.
Pan L; Li Y; He K; Li Y; Li Y
J Multivar Anal; 2020 Jan; 175():. PubMed ID: 32063658
[TBL] [Abstract][Full Text] [Related]
34. MMRM versus MI in dealing with missing data--a comparison based on 25 NDA data sets.
Siddiqui O
J Biopharm Stat; 2011 May; 21(3):423-36. PubMed ID: 21442517
[TBL] [Abstract][Full Text] [Related]
35. Augmented trial designs for evaluation of principal surrogates.
Gabriel EE; Follmann D
Biostatistics; 2016 Jul; 17(3):453-67. PubMed ID: 26825099
[TBL] [Abstract][Full Text] [Related]
36. Trial sequential methods for meta-analysis.
Kulinskaya E; Wood J
Res Synth Methods; 2014 Sep; 5(3):212-20. PubMed ID: 26052847
[TBL] [Abstract][Full Text] [Related]
37. Methods for a longitudinal quantitative outcome with a multivariate Gaussian distribution multi-dimensionally censored by therapeutic intervention.
Sun W; Larsen MD; Lachin JM
Stat Med; 2014 Apr; 33(8):1288-306. PubMed ID: 24258796
[TBL] [Abstract][Full Text] [Related]
38. Adaptive group sequential test with changing patient population.
Feng H; Liu Q
J Biopharm Stat; 2012; 22(4):662-78. PubMed ID: 22651107
[TBL] [Abstract][Full Text] [Related]
39. Statistics and the relationship of clinical research to clinical practice.
Khuder SA; Kahaleh B
J Rheumatol; 2009 Feb; 36(2):219-20. PubMed ID: 19208555
[No Abstract] [Full Text] [Related]
40. An evaluation of inferential procedures for adaptive clinical trial designs with pre-specified rules for modifying the sample size.
Levin GP; Emerson SC; Emerson SS
Biometrics; 2014 Sep; 70(3):556-67. PubMed ID: 24766094
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
